Long-term complete remissions of Kaposi's sarcoma with vinblastine therapy.
Four patients with advanced Kaposi's sarcoma who were treated with weekly vinblastine therapy achieved long-term remissions. Three patients are still in complete remission at two years, four years, and four years respectively, while the fourth achieved excellent partial remission lasting seven-and-one-half years. The regimen produced no toxicity. We suggest the use of vinblastine as a useful chemotherapeutic agent for Kaposi's sarcoma.
D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use*
D014747:Vinblastine